Utilidade do Nível de NT-Pro-BNP no Plasma à Internação em Predizer a Formação de Aneurisma do Ventrículo Esquerdo após Infarto Agudo do Miocárdio com Elevação do Segmento ST
Open Access
- 1 January 2019
- journal article
- research article
- Published by GN1 Sistemas e Publicacoes Ltd. in Arquivos Brasileiros de Cardiologia
- Vol. 113 (6) , 1129-1137
Abstract
Left ventricular aneurysm (LVA) is an important complication of acute myocardial infarction. In this study, we investigated the role of N- Terminal pro B type natriuretic peptide level to predict the LVA development after acute ST-segment elevation myocardial infarction (STEMI). We prospectively enrolled 1519 consecutive patients with STEMI. Patients were divided into two groups according to LVA development within the six months after index myocardial infarction. Patients with or without LVAs were examined to determine if a significant relationship existed between the baseline N- Terminal pro B type natriuretic peptide values and clinical characteristics. A p-value < 0.05 was considered statistically significant. LVA was detected in 157 patients (10.3%). The baseline N- Terminal pro- B type natriuretic peptide level was significantly higher in patients who developed LVA after acute MI (523.5 ± 231.1 pg/mL vs. 192.3 ± 176.6 pg/mL, respectively, p < 0.001). Independent predictors of LVA formation after acute myocardial infarction was age > 65 y, smoking, Killip class > 2, previous coronary artery bypass graft, post-myocardial infarction heart failure, left ventricular ejection fraction < 50%, failure of reperfusion, no-reflow phenomenon, peak troponin I and CK-MB and NT-pro BNP > 400 pg/mL at admission. Our findings indicate that plasma N- Terminal pro B type natriuretic peptide level at admission among other variables provides valuable predictive information regarding the development of LVA after acute STEMI.Keywords
This publication has 21 references indexed in Scilit:
- Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial InfarctionClinical Medicine Insights: Cardiology, 2011
- Comparison of the Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Other Serum Biomarkers as an Early Predictor of ST-Segment Recovery After Primary Percutaneous Coronary InterventionThe American Journal of Cardiology, 2010
- B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevationEuropean Heart Journal, 2004
- Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemiaJACC, 2004
- N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary SyndromesCirculation, 2002
- Transient increase in plasma brain (b‐type) natriuretic peptide after percutaneous transluminal coronary angioplastyClinical Cardiology, 2000
- Left ventricular aneurysm: Clinical and hemodynamic dataClinical Cardiology, 1990
- Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS)The American Journal of Cardiology, 1982
- Detection of left ventricular aneurysms by cross-sectional echocardiography.Circulation, 1976
- Postinfarction ventricular aneurysmAmerican Heart Journal, 1965